![Mobile cancer screenings]([{"url":"https://resources.finalsite.net/images/f_auto,q_auto,t_image_size_1/v1678401927/lsuhscshreveportedu/pzfng1husolylh2bjdfg/fwccpartnersinwellnessnews.jpg","width":256},{"url":"https://resources.finalsite.net/images/f_auto,q_auto,t_image_size_2/v1678401927/lsuhscshreveportedu/pzfng1husolylh2bjdfg/fwccpartnersinwellnessnews.jpg","width":512},{"url":"https://resources.finalsite.net/images/f_auto,q_auto,t_image_size_3/v1678401927/lsuhscshreveportedu/pzfng1husolylh2bjdfg/fwccpartnersinwellnessnews.jpg","width":800},{"url":"https://resources.finalsite.net/images/f_auto,q_auto/v1678401927/lsuhscshreveportedu/pzfng1husolylh2bjdfg/fwccpartnersinwellnessnews.jpg","width":930}])
KALB5 - The LSUHS Feist-Weiller Cancer Center Partners in Wellness mobile screening unit is traveling through North Louisiana to offer mobile cancer screenings.
North Louisiana's only academic cancer center.
Feist-Weiller Cancer Center began as a designated Center of Excellence in Cancer Research, Treatment and Education in 1993, named following a generous philanthropic gift by Carroll Feist to honor the Feist and Weiller families. Today, FWCC brings cancer research, clinical care, and medical education together as we work toward new and improved models of cancer prevention and treatment.
Feist-Weiller Cancer Center is supported by the partnership between Ochsner LSU Health Shreveport and LSU Health Shreveport. Feist-Weiller's research and education initiatives are backed by the academic mission of LSU Health Shreveport while Ochsner LSU Health Shreveport oversees the delivery of clinical care at FWCC. Together, collaboration between cancer researchers and treating physicians fosters a comprehensive understanding of cancer, increased access to treatments, and opportunities for patients to participate in clinical trials.
FWCC has two major roles:
-
To advance cancer care and reduce the burden of cancer in North Louisiana
-
To develop research programs, faculty, and facilities that will lead to better and more innovative approaches to cancer prevention, diagnosis, and treatment
Loading from Vimeo...
Integrate to Accelerate
Among the signature strengths of Feist-Weiller Cancer Center is translational research. In translational cancer research, basic science findings are translated through clinical care into tomorrow's improved therapies. Physicians and scientists take clinical problems from the bedside to the research laboratory where solutions are generated that come back to the bedside. This type of research allows the scientific discoveries to more rapidly become practical applications that can be used in assessment and treatment of cancer patients.
Feist-Weiller Cancer Center is focused on the coordinated growth of clinical and research programs aimed at cancer prevention and control. In 2021, we began reorganizing our cancer research programs to strategically address four critical areas of cancer research:
- Genetics and Cancer Biology
- Viral Oncology and Immunology
- Cancer Preventative Control and Health Care Disparities
- Developmental: Clinical and Translational Oncology/Cancer Therapeutics
Mission and Values
Engage in Multidisciplinary, Translational Cancer Research
Provide patients cutting-edge Treatment with access to national cancer Clinical Trials
Educate physicians and the community about the Prevention, Treatment, and Science of cancer
Our team is committed to bringing life-saving discoveries about cancer to all of Louisiana and beyond. Collaboration between cancer researchers and treating physicians fosters a more comprehensive understanding of cancer. Our faculty:
- Conduct laboratory research and clinical research to discover better methods of preventing and treating cancer
- Provide adult and pediatric patients with state-of-the-art cancer care, regardless of their ability to pay
- Educate and train Hematology/Oncology Fellows, community physicians, and local residents about the most modern cancer treatments so all patients will receive the best possible cancer care
- Supply Louisiana communities with cancer screenings and education materials for prevention through Partners in Wellness, a unique community cancer screening program
Latest News on Feist-Weiller Cancer Center
![Feist-Weiller Cancer Center hosted a Present Wrapping Party to support Sickle Cell Patients]([{"url":"https://resources.finalsite.net/images/f_auto,q_auto,t_image_size_1/v1670438062/lsuhscshreveportedu/zwozmcffpxezbvk21cvt/FWCCGiftwrapnews.jpg","width":256},{"url":"https://resources.finalsite.net/images/f_auto,q_auto,t_image_size_2/v1670438062/lsuhscshreveportedu/zwozmcffpxezbvk21cvt/FWCCGiftwrapnews.jpg","width":512},{"url":"https://resources.finalsite.net/images/f_auto,q_auto/v1670438062/lsuhscshreveportedu/zwozmcffpxezbvk21cvt/FWCCGiftwrapnews.jpg","width":520}])
On Monday, December 5th, Feist-Weiller Cancer Center held a present wrapping party today on the LSUHS campus to benefit the children of FWCC's adult sickle cell patients.
![Prevalence of breast cancer in Black population]([{"url":"https://resources.finalsite.net/images/f_auto,q_auto,t_image_size_1/v1666879804/lsuhscshreveportedu/tlmrjfzgb9ourmyza0nv/KSLAFWCCBreastCancernews.jpg","width":256},{"url":"https://resources.finalsite.net/images/f_auto,q_auto,t_image_size_2/v1666879804/lsuhscshreveportedu/tlmrjfzgb9ourmyza0nv/KSLAFWCCBreastCancernews.jpg","width":512},{"url":"https://resources.finalsite.net/images/f_auto,q_auto,t_image_size_3/v1666879804/lsuhscshreveportedu/tlmrjfzgb9ourmyza0nv/KSLAFWCCBreastCancernews.jpg","width":800},{"url":"https://resources.finalsite.net/images/f_auto,q_auto/v1666879804/lsuhscshreveportedu/tlmrjfzgb9ourmyza0nv/KSLAFWCCBreastCancernews.jpg","width":926}])
KSLA12 - Overall, the breast cancer death rate dropped 43 percent between 1989 and 2020. However, Black women have a 40 percent higher mortality rate than other ethnic groups then it comes to breast cancer. Dr. Sarah Thayer, Director of the Feist-Weiller Cancer Center at LSUHS shares more about these disparities.
![FWCC director discusses common myths, misconceptions about breast cancer]([{"url":"https://resources.finalsite.net/images/f_auto,q_auto,t_image_size_1/v1666360701/lsuhscshreveportedu/gr9x3xsfi5sypyfeauwg/BreastCancernews.jpg","width":256},{"url":"https://resources.finalsite.net/images/f_auto,q_auto,t_image_size_2/v1666360701/lsuhscshreveportedu/gr9x3xsfi5sypyfeauwg/BreastCancernews.jpg","width":512},{"url":"https://resources.finalsite.net/images/f_auto,q_auto,t_image_size_3/v1666360701/lsuhscshreveportedu/gr9x3xsfi5sypyfeauwg/BreastCancernews.jpg","width":800},{"url":"https://resources.finalsite.net/images/f_auto,q_auto/v1666360701/lsuhscshreveportedu/gr9x3xsfi5sypyfeauwg/BreastCancernews.jpg","width":933}])
KSLA - Dr. Sarah Thayer, Director of Feist-Weiller Cancer Center at LSUHS talks about the risks, family history, and how to reduce the risk of getting breast cancer during Breast Cancer Awareness Month.
![Cancer Center Leaders Selected for AACI Board]([{"url":"https://resources.finalsite.net/images/f_auto,q_auto,t_image_size_1/v1644441347/lsuhscshreveportedu/xh6dh5gukzbfm4sbj4xc/Thayernews.jpg","width":256},{"url":"https://resources.finalsite.net/images/f_auto,q_auto,t_image_size_2/v1644441347/lsuhscshreveportedu/xh6dh5gukzbfm4sbj4xc/Thayernews.jpg","width":512},{"url":"https://resources.finalsite.net/images/f_auto,q_auto/v1644441347/lsuhscshreveportedu/xh6dh5gukzbfm4sbj4xc/Thayernews.jpg","width":520}])
Newswise - Sarah Thayer, MD, PhD, Director of the Feist-Weiller Cancer Center at LSUHS, was elected as a new board member of the Association of American Cancer Institutes during the AACI/CCAF Annual Meeting, October 2-4.
Feist-Weiller Cancer Center
Center of Excellence in Cancer Research, Treatment and Education